Luluel Khan
Papers
1
Total Citations
2
H-Index
1
About
Luluel Khan is a radiation oncologist whose research focuses on optimizing stereotactic radiation therapy for patients with brain metastases. Her work specifically investigates hypofractionated stereotactic radiation therapy (hfSRT), a technique that delivers precise, high-dose radiation in fewer sessions to both intact brain tumors and postoperative surgical cavities. In her 2014 study, Khan examined clinical outcomes of hfSRT, demonstrating its effectiveness in achieving local tumor control while minimizing radiation toxicity to surrounding healthy brain tissue. Although this foundational paper has garnered 2 citations, her contributions are part of a broader effort to refine non-invasive treatment paradigms for metastatic brain disease—a critical area given the rising incidence of brain metastases. Khan’s research helps bridge gaps in postoperative management, offering patients a safer alternative to whole-brain radiation. Her work underscores the importance of dose fractionation and target precision in improving quality of life and survival outcomes. As a clinician-scientist, Khan continues to advance evidence-based protocols that shape modern neuro-oncology practice.
Research Focus
Key Achievements
Top Papers
- 1